Atlas Trials

Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects

Clinical trial NCT01851603 · TERMINATED

Trial details

NCT number
NCT01851603
Sponsor
University of Colorado, Denver
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2013-06-01
Primary completion
2016-08-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.